Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07451847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Name: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. — clinical trial record (NCT07451847)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PREP-ANCA

StatusNot Yet Recruiting

PhasePhase 4

SponsorAssistance Publique - Hôpitaux de Paris

Started2026-02

View on ClinicalTrials.gov ↗

Assistance Publique - Hôpitaux de Paris

1,338 trials monitored

See 38 trials at risk

The PREP-ANCA study seeks to establish a more personalized treatment strategy for ANCA-associated vasculitides by assessing the efficacy of pre-emptive rituximab administration upon ANCA repositivity in preventing relapses in granulomatosis with polyangiitis and microscopic polyangiitis.

Trial Details

NCT Number	NCT07451847
Lead Sponsor	Assistance Publique - Hôpitaux de Paris Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions	ANCA Associated Vasculitis (AAV), Polyangiitis (GPA), Microscopic Polyangiitis (MPA)
Enrollment	70 participants
Start Date	2026-02
Primary Completion	2030-02 (estimated)
Study Completion	2030-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-05